Acitretin improves psoriasis in a dose-dependent fashion

Journal of the American Academy of Dermatology

Volumn 18, Issue 4, 1988, Pages 655-662

  Goldfarb, Michael T ^a   Ellis, Charles N ^a   Gupta, Aditya K ^a   Tincoff, Theresa ^a   Hamilton, Ted A ^a   Voorhees, John J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ETRETIN; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ARTHRALGIA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHEILITIS; CHILL; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRY EYE; DRY NOSE; EDEMA; FATIGUE; FEMALE; GRANULATION TISSUE; HEADACHE; HUMAN; MALE; MYALGIA; PRIORITY JOURNAL; PRURITUS; PSORIASIS; SIDE EFFECT; SKIN ABRASION; XEROSIS;

ACITRETIN; ADULT; CHEILITIS; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMAN; PSORIASIS; SUPPORT, NON-U.S. GOV'T; TRETINOIN;

EID: 0023926321     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(88)70086-9     Document Type: Article

References (14)

1. International studies of the efficacy of etretinate in the treatment of psoriasis
2. Etretinate therapy
3. Etretinate kinetics during chronic dosing in severe psoriasis
4. Retinoid concentrations in skin, serum, and adipose tissue of patients treated with etretinate
5. Etretinate: persistent serum levels of a potent teratogen
6. Teratogene Wirkung von Etretinat beim Menschen
7. Malformation of fetus conceived 4 months after termination of maternal etretinate treatment
8. Pharmacokinetic and metabolic pathways of systemically applied retinoids
9. Multiple dose pharmacokinetics of Ro 10-1670, the main metabolite of etretinate (Tigason)
10. Teratogenesis and reproductive safety evaluation of the retinoid etretin (Ro 10-1670)
11. Clinical evaluation of an aromatic retinoid, Ro 10-1670, in severe psoriasis
12. Clinical efficacy of Ro 10-1670, the main metabolite of Tigason; a pilot study in psoriasis
13. Etretin therapy for severe psoriasis: evaluation of initial clinical responses
14. Retinoid toxicity: lipids